Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-oncology Group.
about
Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysisMultifactorial analysis of predictors of outcome in pediatric intracranial ependymomaNew chemotherapy strategies and biological agents in the treatment of childhood ependymomaImpairment of intellectual functions after surgery and posterior fossa irradiation in children with ependymoma is related to age and neurologic complicationsChromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma.Intracranial ependymomas in childhood--a retrospective review of sixty-two children.Outcome of infants and young children with newly diagnosed ependymoma treated on the "Head Start" III prospective clinical trial.Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups.Effects of surgical resection and adjuvant therapy on pediatric intracranial ependymomas.Intracranial ependymoma: long-term results in a series of 21 patients treated with stereotactic (125)iodine brachytherapy.Role of stereotactic radiosurgery and fractionated stereotactic radiotherapy in the management of intracranial ependymoma.Postoperative radiotherapy for ependymomaConformal radiotherapy after surgery for paediatric ependymoma: a prospective study.Treatment of pediatric brain tumors.Magnetic resonance imaging findings of extraventricular anaplastic ependymoma: A report of 11 casesProton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients.Intracranial ependymoma: factors affecting outcome.The evolving role of surgery in the management of pediatric brain tumors.Ependymoma: an update.Supratentorial ependymoma in children: to observe or to treat following gross total resection?Spinal cord ependymomas in children and adolescents.Multidisciplinary management of pediatric intracranial ependymoma.The role of resection alone in select children with intracranial ependymoma: the Canadian Pediatric Brain Tumour Consortium experience.Pediatric Ependymoma.Surgical resection of fourth ventricular ependymomas: case series and technical nuances.Pediatric intracranial ependymoma: the roles of surgery, radiation and chemotherapy.Pencil beam scanning proton therapy for pediatric intracranial ependymoma.Evaluation of chromosome 1q gain in intracranial ependymomas.Long-term life expectancy for children with ependymoma and medulloblastoma.Malignant Transformation of Grade II Ependymoma in a 2-Year-Old Child: Case Report.Posterior fossa ependymoma in childhood: 60 years event-free survival after partial resection—a case report.A retrospective analysis of recurrent intracranial ependymoma.Intracranial ependymomas treated with radiotherapy: long-term results from a single institution.Current treatment options for pediatric and adult patients with ependymoma.Pediatric infratentorial ependymoma: prognostic significance of anaplastic histology.Supratentorial gross-totally resected non-anaplastic ependymoma: population based patterns of care and outcomes analysis.Prognostic Implications of Histological Clear Cells in High-Grade Intracranial Ependymal Tumors: A Retrospective Analysis from a Tertiary Care Hospital in Pakistan.Post-operative radiation improves survival in children younger than 3 years with intracranial ependymoma.Pediatric anaplastic parenchymal ependymoma: case report.Intensity modulated radiation therapy or stereotactic fractionated radiotherapy for infratentorial ependymoma in children: a multicentric study.
P2860
Q21136141-8A4BABEB-C9C5-447E-80DC-20FB4BA272F2Q24646111-232BB216-9CBB-4140-A08F-C0D50D583F2CQ24658324-1D7A824E-D602-4922-9702-15F04E82C4AEQ33315598-7C07FA53-061B-42DB-A8FF-833FEB6EFBAEQ33871385-C43685A6-88FB-46C3-905D-DAEC3898F244Q33884410-4A2BBBFB-578F-4360-80F4-D15DD491F95BQ33993483-DCF75A4D-301C-4DA5-A852-36B52753B048Q35748208-89616B42-09E4-4A6C-B700-AE0E1F9C8739Q36198592-2A4946BA-3303-4546-9182-4E85183F133BQ36373774-CA258330-F184-4229-8F1B-332CA27CDBECQ36453268-5A84A880-EA59-4863-8CF5-1E47F7736284Q36537047-90F73FAC-2008-4423-9429-35263E6ED87BQ36737176-3B6F1703-51A6-4274-934C-DFC4C25E45CAQ36953476-6C385F08-B300-4D82-940C-93A03EC84057Q37205992-D3169D8D-A8BB-4067-97B8-5596274DD770Q37268903-45F936C6-7B85-418E-A471-0D234BFA5E71Q37414361-1880250C-5919-4FC5-BCE3-63135FA5EEF2Q37617836-B3263E29-ABDA-40A9-8336-AF818415E881Q37617847-19C71D62-E4C9-4C8C-AF33-1FFC69F2F6F0Q37849262-0E70435B-262C-475C-A2DA-DF780C69E903Q38041984-780D8F7F-BB90-462F-837A-1E2A7C8EAFD7Q38233102-2E58BB7B-E079-439D-BA07-9BE004D8F5BFQ38267747-B9570CDA-DFE2-413D-BA8A-63139E3F077FQ38616800-AFB8289E-7E11-45AC-BC25-0B6C1A86D6A3Q38990024-18EEB26F-A410-4E63-AFEC-4A12D3B6D3D4Q39719582-9DF17D72-DFB2-4FE4-9C80-83B17293CF43Q39946074-9AB84290-EF86-4305-8DD3-3959FEC9D720Q40150706-8C6665F2-B843-485D-B371-0E1746767427Q40897111-6E88487B-6913-4B03-AB70-83BA1C17E203Q42408974-0087F82A-00C2-4482-BB99-D05D8B0821F2Q43107700-95B609FF-FD99-45CB-914B-50670F8B1CF1Q45960095-D6744B93-AEC4-462B-906B-90FF442472C0Q48091317-A0A6E0E4-F06E-4D5C-8B97-AC39D1B789CFQ48439500-DB0EFB73-B11D-4B95-9E49-83F66F46AC9FQ48935560-2E2F72B7-AFC2-4338-B12D-B95A584B3B00Q48961952-064AB439-F3FB-40E8-96D0-9B597DD8C3A1Q55080814-2671E3D3-09F0-4F22-8933-B9E86D96CAB2Q55463025-7892EBBF-00BE-48A3-8C7C-B32F824C5CF9Q55463638-8B86044C-7DEF-4174-AC7E-E5DC1959B69DQ55463923-BEC7273B-1BBA-43A6-92EC-D8003D587501
P2860
Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-oncology Group.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Analyses of prognostic factors ...... ediatric Neuro-oncology Group.
@en
type
label
Analyses of prognostic factors ...... ediatric Neuro-oncology Group.
@en
prefLabel
Analyses of prognostic factors ...... ediatric Neuro-oncology Group.
@en
P2093
P1476
Analyses of prognostic factors ...... Pediatric Neuro-oncology Group
@en
P2093
A B del Prever
F Giangaspero
F Lombardi
G Perilongo
L Andreussi
P2860
P356
10.1002/(SICI)1096-911X(199708)29:2<79::AID-MPO3>3.0.CO;2-O
P50
P577
1997-08-01T00:00:00Z